When “Administered” Meets Reality: Why Measuring Wounds for Skin Substitutes Isn’t as Simple as It Seems

When “Administered” Meets Reality: Why Measuring Wounds for Skin Substitutes Isn’t as Simple as It Seems

CMS’s 2026 wastage proposal reduces billing to “administered” units, but defining what’s truly administered exposes a major gap between policy assumptions and wound-care reality.

The Centers for Medicare & Medicaid Services’ (CMS) proposed 2026 skin substitute wastage policy introduces a deceptively simple rule: providers may bill only for units that are “administered,” not for those that are “discarded.”

On paper, this sounds straightforward. In practice, it opens the door to an extremely complicated measurement problem.

Once wastage is eliminated, a new question takes center stage: What exactly counts as “administered”?

Many assume the answer is simple. Measure the wound, select a graft that matches that measurement, and apply it. Anyone who treats complex wounds knows this is far from reality.

The Core Problem: What Do We Mean by “Wound Area”?

When clinicians talk about wound size, they are often referring to one of two very different measurements: The 2D wound opening area (the area of the opening at skin level) that is historically estimated using length × width or the 3D wound bed surface area (measuring the total internal surface of the wound, including sidewalls, tunnels, and irregular contours). One clinician captured this distinction perfectly, “It’s a little like painting a room. Do you want to just paint the ceiling, or do you want to paint the walls too?”

For skin substitutes to function as intended, and to remain compliant with FDA labeling, they should contact and protect the wound bed itself. That means the 3D wound bed surface area is the clinically relevant measurement.

The Hidden Scale of the Difference

Most people underestimate how large the gap can be between 2D opening area and true 3D wound bed surface area.

Using basic geometric models:

  • Shallow wounds: up to ~20% larger than the opening
  • Moderate-depth wounds: up to ~100% larger
  • Deep or complex wounds: up to 400% larger—or more

And these are conservative estimates.

Importantly, none of this can be accurately calculated with simple L × W × D formulas. Measuring true wound bed surface area requires full 3D surface mapping, which is technologically challenging measurement when it can be done at all.

Estimation Exists; Precision Does Not

Shaun Carpenter, MD, CWSP, DABWMS has proposed a clever drape-based estimation method to better approximate wound bed surface area. Techniques like this move the field forward. But even with innovative approaches, a highy precise, standardized, and widely available method for measuring 3D wound bed surface area does not exist. This means any policy framework that assumes centimeter-by-centimeter precision is operating ahead of real-world capabilities.

Edge Overlap: The Second Multiplier

Depth isn’t the only factor that expands required graft size. Many skin substitutes require overlap beyond the wound margins to:

  • Cover wound edges
  • Facilitate fixation
  • Meet manufacturer Instructions for Use (IFUs)

Even a conservative 0.5 cm overlap around the perimeter can dramatically increase the required graft area:

  • Small wounds: additional 100–200% of the wound opening area
  • Large wounds: often 25% or more additional area

This overlap is not optional. It is frequently part of proper application technique.

So What Size Skin Substitute Should Actually Be “Administered”?

The most honest answer is, it varies widely.

Appropriate graft size depends on:

  • Wound depth
  • Geometry and irregularity
  • Presence of undermining or tunneling
  • Required edge overlap
  • Product-specific handling and fixation requirements

In many cases, the clinically appropriate graft is substantially larger than the 2D wound opening measurement.

This is not waste. This is not inefficiency. This is geometry and biology.

The Risk of Oversimplification

A policy environment that implicitly expects: “Measure the wound opening → pick a perfectly matched graft → zero excess”, simply ignores wound care reality.

The Best Measurement Tool We Have Today

Given all the variables that must be considered, the most reliable measurement system we have is clinicians at the bedside. Their assessment should include:

  • Visual assessment
  • Tactile examination
  • Clinical judgment
  • Thorough documentation
  • Wound photography to support rationale

Digital tools if available can add consistency and strengthen the record. Clear documentation explaining why a specific graft size was selected is currently the strongest bridge between clinical reality and administrative requirements.

There is and should be considerable latitude left to clinicians in fitting specific grafts to the unique needs of specific patients and specific wounds. Clinicians should “administer” the size of graft needed to do the job.

More News & Updates

Stay Up-To-Date With
Venture Medical

Jan 30, 2026

What size is that wound again anyway?

CMS's 2026 skin sub wastage policy allows providers to bill onlyfor units "administered," not "discarded." Cue the nightmare scenario: measuring grafts centimeter by centimeter to exactly fit the "wound area."

Jan 9, 2026

Learn More About Bill HR 6852

HR 6852 is gaining bipartisan traction in the House. If passed, it would address all three of these issues. This bill aims to restore fair application payments and modernizing the PFS rate structure.

Jan 9, 2026

Three Hits in One Week: The 85% Rule Expands

This is the third major reimbursement change or clarification impacting wound care providers in a single week — and unfortunately, it’s another step in the wrong direction.

Dec 28, 2025
John Schroeder and Howard Walthall
John Schroeder and Howard Walthall

What? Now the LCDs Are Cancelled?

Dec 15, 2025

2025: A Year of Momentum, Milestones, and Meaningful Impact

We want to take this time to reflect on 2025 and express our gratitude to everyone who was a part of our journey this year.

Dec 15, 2025

Looking Ahead To 2026

Find out what Venture Medical has in store for 2026 and what that means for our community.

Nov 20, 2025
Michael N. Desvigne MD, FACS, CWS, FACCWS
Michael N. Desvigne MD, FACS, CWS, FACCWS

The Crystal Ball: NO ONE HAS IT! A New Chapter in Wound Care From a Plastic Surgeons Perspective

Nov 6, 2025

Venture Medical Issues Statement on CMS 2026 Physician Fee Schedule Final Rule

‍Company reaffirms its commitment to patient access, clinical excellence, and responsible reimbursement reform under the new CMS framework.

Oct 15, 2025

Wound Care Compliance & Audit Defense Essentials: Inside the Series Every Provider Should Be Watching

Venture Medical’s Wound Care Compliance & Audit Defense Essentials webinar series empowers clinicians and administrators to navigate today’s complex regulatory environment with clarity and confidence. Through expert-led sessions covering legal, billing, and investigative insights, the series helps providers stay compliant, reduce audit risk, and strengthen their practice for the future.

Oct 15, 2025
Carey Brandenburg
Carey Brandenburg

Running A Mobile Wound Practice With Confidence

Provider Jessica Hoge, MD shares how she’s streamlined her workflow, improved patient care, and eliminated frustration.